Monitoring the spread of SARS-CoV-2 variants in Moscow and the Moscow region using targeted high-throughput sequencing
Nadezhda I. BorisovaiD, Ivan A. KotoviD, A A KolesnikoviD, V.V. Kaptelova, Anna S. SperanskayaiD, L. Yu. KondrashevaiD, E. V. TivanovaiD, Камиль Фаридович ХафизовiD, В. Г. АкимкинiD
Abstract
Since the outbreak of the COVID-19 pandemic caused by the SARS-CoV-2 coronavirus, the international community has been concerned about the emergence of mutations that alter the biological properties of the pathogen, for example, increasing its infectivity or virulence. In particular, since the end of 2020, several variants of concern have been identified around the world, including variants "alpha" (B.1.1.7, "British"), "beta" (B.1.351, "South African"), "gamma" (P.1, "Brazilian") and "delta" (B.1.617.2, "Indian"). However, the existing mechanism for searching for important mutations and identifying strains may not be effective enough, since only a relatively small fraction of all identified pathogen samples can be examined for genetic changes by whole genome sequencing due to its high cost. In this study, we used the method of targeted high-throughput sequencing of the most significant regions of the gene encoding the S-glycoprotein of the SARS-CoV-2 virus, for which a primer panel was developed. Using this technique, we examined 579 random samples obtained from patients in Moscow and the Moscow region with coronavirus infection from February to June 2021. The study demonstrated the dynamics of the representation in the Moscow region of a number of SARS-CoV-2 strains and its most significant individual mutations in the period from February to June 2021. It was found that the strain B.1.617.2 began to spread rapidly in Moscow and the Moscow region in May, and in June it became dominant, partially displacing other varieties of the virus. The results obtained make it possible to accurately determine the belonging of the samples to the abovementioned and some other strains. The approach can be used to standardize the procedure for searching for new and existing epidemiologically significant mutations in certain regions of the SARS-CoV-2 genome, which allows studying a large number of samples in a short time and to get a more detailed picture of the epidemiological situation in the region.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 33
- FWCI
- 2.53
- Field percentile
- top 8%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Sequencing using a two-steps strategy reveals high genetic diversity in the S gene of SARS-CoV-2 after a high transmission period in Tunis, Tunisia.
W. Fares, K. Ghedira, … H. Triki·bioRxiv·Jun 18, 2021
- SARS-CoV-2 variant evolution in the United States: High accumulation of viral mutations over time likely through serial Founder Events and mutational bursts.
Rafail Nikolaos Tasakis, Georgios Samaras, … Marilyn Diaz·PLoS ONEPeer-reviewed·Jul 23, 2021
- Tracking the circulating SARS-CoV-2 variants in Turkey: Complete genome sequencing and molecular characterization of 1000 SARS-CoV-2 samples
Faruk Berat Akçeşme, Tuğba Kul Köprülü, … Şaban Teki̇n·bioRxiv·Apr 19, 2022
- Genetic Diversity and Genomic Epidemiology of SARS-COV-2 in Morocco
Bouabid Badaoui, Khalid Sadki, … Lina Tazi·Biosafety and HealthPeer-reviewed·Feb 6, 2021
- Survey of SARS-CoV-2 genetic diversity in two major Brazilian cities using a fast and affordable Sanger sequencing strategy.
Erick Gustavo Dorlass, Karine Lima Lourenço, … Santuza Maria Ribeiro Teixeira·GenomicsPeer-reviewed·Oct 28, 2021
- Mutation density changes in SARS-CoV-2 are related to the pandemic stage but to a lesser extent in the dominant strain with mutations in spike and RdRp
Doğa Eskier, Aslı Süner, … Yavuz Oktay·PeerJPeer-reviewed·Aug 19, 2020